What is the next best step in management for a patient with a scaly, oozing lesion on the nipple, no palpable breast masses, and normal breast imaging results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nipple Biopsy is the Next Best Step

The correct answer is C: Nipple biopsy. A scaly, oozing nipple lesion that persists for weeks requires tissue diagnosis to exclude Paget disease of the nipple, which represents ductal carcinoma in situ (DCIS) extending into the nipple epidermis and is found in over 80% of cases with persistent unilateral nipple lesions. 1

Why Biopsy is Mandatory Despite Normal Imaging

  • Normal imaging does not exclude malignancy in nipple lesions. Paget disease can present with isolated nipple changes without detectable underlying masses or imaging abnormalities in a significant proportion of cases. 1

  • The clinical presentation is highly suspicious. A persistent unilateral scaly, oozing nipple lesion lasting weeks is the classic presentation of Paget disease, which requires histologic confirmation. 2, 1

  • Mammography and ultrasound have limited sensitivity for nipple-specific pathology. These modalities are designed to detect parenchymal lesions, not intraepidermal malignancies like Paget disease that may exist without an underlying mass. 1

Why Other Options Are Inappropriate

Topical Steroid Cream (Option B) is Dangerous

  • Empiric treatment without tissue diagnosis risks missing cancer. Eczema of the nipple is a differential diagnosis for Paget disease, but the two cannot be reliably distinguished clinically. 1

  • Steroid application may temporarily improve symptoms while allowing malignancy to progress. This creates a false sense of reassurance and delays definitive diagnosis. 1

  • The standard of care mandates biopsy before treatment. In any patient with a persistent unilateral nipple lesion, tissue sampling is required to exclude Paget disease. 1

Dermatology Referral (Option A) is Suboptimal

  • This introduces unnecessary delay in cancer diagnosis. While dermatologists can perform biopsies, the patient should proceed directly to tissue diagnosis rather than adding another consultation step. 1

  • Breast surgeons or breast specialists are better equipped to manage this presentation. They can coordinate immediate biopsy and subsequent breast imaging (including MRI if malignancy is confirmed) to assess for multifocal disease. 1

The Specific Biopsy Approach

  • Punch biopsy or wedge biopsy of the nipple lesion itself is required. The sample must include the abnormal nipple skin to capture the intraepidermal malignant cells characteristic of Paget disease. 2, 1

  • Core needle biopsy of breast parenchyma is insufficient. The pathology in Paget disease involves the nipple epidermis, not necessarily the underlying breast tissue. 2

Post-Biopsy Management Algorithm

  • If Paget disease is confirmed: Breast MRI is indicated to detect underlying DCIS or invasive cancer (present in >80% of cases) and assess for multifocal disease, especially if breast-conserving surgery is planned. 1

  • If benign (eczema or erosive adenomatosis): Appropriate topical therapy can then be initiated with confidence. 1

  • If biopsy is non-diagnostic or discordant: Repeat biopsy or excisional biopsy is necessary until concordance between clinical presentation and pathology is achieved. 3

Critical Pitfall to Avoid

Never assume a nipple lesion is benign based on normal imaging alone. The absence of a palpable mass and normal mammogram/ultrasound does not exclude Paget disease, which can exist as an isolated finding in the nipple epidermis without detectable parenchymal abnormalities. 1 Delaying biopsy to trial topical treatments or await specialist consultation allows potential malignancy to progress and represents a significant medicolegal risk.

References

Research

Clinical abnormalities of the nipple-areola complex: The role of imaging.

Diagnostic and interventional imaging, 2015

Guideline

Management of New Breast Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.